Review

Chromosome & Chromatin Research, Murdoch Children’s Research Institute, Flemington Road, Parkville, Victoria 3052, Australia.

Email the corresponding author at lee.wong@mcri.edu.au

Published Online:9 Nov 2010https://doi.org/10.2217/epi.10.49

View article

Abstract

Telomeres are protective chromosomal structures highly conserved from primitive organisms to humans. The evolutionary conservation of telomere DNA implicates the importance of telomeric structure for basic cellular functions. Loss of telomere function causes chromosomal fusion, activation of DNA damage checkpoint responses, genome instability and impaired stem cell function. In human cells, the telomeric chromatin consists of TTAGGG repeats associated with a complex of proteins known as Shelterin. It is also organized in nucleosomes enriched with epigenetic modifications of ‘closed’ or ‘silenced’ chromatin states, including DNA hypermethylation and trimethylation of H3K9 and H4K20. These heterochromatin marks serve as a higher-order level of control of telomere length and structural integrity. Recent studies have shown that the telomere nucleosome in pluripotent embryonic stem cells is characterized by a more ‘open’ chromatin state that switches to become more repressive during differentiation. Conversely, the reprogramming of adult somatic cells into induced pluripotent cells results in the switch in telomeric chromatin from a repressive to a more open embryonic stem cell-like state, coupled with the restoration of telomere length. These findings indicate that telomeric chromatin is dynamic and reprogrammable, and has a fundamental role in the maintenance of embryonic stem cell pluripotency.

Keywords:

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

1 Makarov VL, Hirose Y, Langmore JP: Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell88(5),657–666 (1997).Crossref, Medline, CAS, Google Scholar
2 Wellinger RJ, Sen D: The DNA structures at the ends of eukaryotic chromosomes. Eur. J. Cancer33(5),735–749 (1997).Crossref, Medline, CAS, Google Scholar
3 Wright WE, Tesmer VM, Huffman KE, Levene SD, Shay JW: Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev.11(21),2801–2809 (1997).Crossref, Medline, CAS, Google Scholar
4 Griffith JD, Comeau L, Rosenfield S et al.: Mammalian telomeres end in a large duplex loop. Cell97(4),503–514 (1999).Crossref, Medline, CAS, Google Scholar
5 Greider CW: Telomeres do D-loop-T-loop. Cell97(4),419–422 (1999).Crossref, Medline, CAS, Google Scholar
6 Collins K: Mammalian telomeres and telomerase. Curr. Opin Cell Biol.12(3),378–383 (2000).Crossref, Medline, CAS, Google Scholar
7 Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell43(2 Pt 1),405–413 (1985).Crossref, Medline, CAS, Google Scholar
8 Greider CW, Blackburn EH: The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell51(6),887–898 (1987).Crossref, Medline, CAS, Google Scholar
9 Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR: Protein composition of catalytically active human telomerase from immortal cells. Science315(5820),1850–1853 (2007).Crossref, Medline, CAS, Google Scholar
10 Mitchell JR, Wood E, Collins K: A telomerase component is defective in the human disease dyskeratosis congenita. Nature402(6761),551–555 (1999).Crossref, Medline, CAS, Google Scholar
11 Nakamura TM, Morin GB, Chapman KB et al.: Telomerase catalytic subunit homologs from fission yeast and human. Science277(5328),955–959 (1997).Crossref, Medline, CAS, Google Scholar
12 Feng J, Funk WD, Wang SS et al.: The RNA component of human telomerase. Science269(5228),1236–1241 (1995).Crossref, Medline, CAS, Google Scholar
13 Pogacic V, Dragon F, Filipowicz W: Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol. Cell Biol.20(23),9028–9040 (2000).Crossref, Medline, CAS, Google Scholar
14 Dragon F, Pogacic V, Filipowicz W: In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs. Mol. Cell Biol.20(9),3037–3048 (2000).Crossref, Medline, CAS, Google Scholar
15 Mitchell JR, Collins K: Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase. Mol. Cell6(2),361–371 (2000).Crossref, Medline, CAS, Google Scholar
16 Calado RT, Young NS: Telomere diseases. N. Engl. J. Med.361(24),2353–2365 (2009).Crossref, Medline, CAS, Google Scholar
17 Vulliamy T, Marrone A, Goldman F et al.: The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature413(6854),432–435 (2001).Crossref, Medline, CAS, Google Scholar
18 Blasco MA, Lee HW, Rizen M, Hanahan D, DePinho R, Greider CW: Mouse models for the study of telomerase. Ciba Found. Symp.211,160–170, discussion 170–166 (1997).Medline, CAS, Google Scholar
19 Blasco MA, Lee HW, Hande MP et al.: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell91(1),25–34 (1997).Crossref, Medline, CAS, Google Scholar
20 Samper E, Flores JM, Blasco MA: Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc^-/- mice with short telomeres. EMBO Rep.2(9),800–807 (2001).Crossref, Medline, CAS, Google Scholar
21 Leri A, Franco S, Zacheo A et al.: Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J.22(1),131–139 (2003).Crossref, Medline, CAS, Google Scholar
22 Herrera E, Martinez AC, Blasco MA: Impaired germinal center reaction in mice with short telomeres. EMBO J.19(3),472–481 (2000).Crossref, Medline, CAS, Google Scholar
23 Herrera E, Samper E, Blasco MA: Telomere shortening in mTR^-/- embryos is associated with failure to close the neural tube. EMBO J.18(5),1172–1181 (1999).Crossref, Medline, CAS, Google Scholar
24 Flores I, Cayuela ML, Blasco MA: Effects of telomerase and telomere length on epidermal stem cell behavior. Science309(5738),1253–1256 (2005).Crossref, Medline, CAS, Google Scholar
25 Armanios M: Syndromes of telomere shortening. Annu. Rev. Genomics Hum. Genet.10,45–61 (2009).Crossref, Medline, CAS, Google Scholar
26 Calado RT, Regal JA, Kleiner DE et al.: A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS ONE4(11),e7926 (2009).Crossref, Medline, Google Scholar
27 Calado RT, Young NS: Telomere maintenance and human bone marrow failure. Blood111(9),4446–4455 (2008).Crossref, Medline, CAS, Google Scholar
28 Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med.3(11),1271–1274 (1997).Crossref, Medline, CAS, Google Scholar
29 Bryan TM, Marusic L, Bacchetti S, Namba M, Reddel RR: The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum. Mol. Genet.6(6),921–926 (1997).Crossref, Medline, CAS, Google Scholar
30 Bryan TM, Reddel RR: Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur. J. Cancer33(5),767–773 (1997).Crossref, Medline, CAS, Google Scholar
31 Dunham MA, Neumann AA, Fasching CL, Reddel RR: Telomere maintenance by recombination in human cells. Nat. Genet.26(4),447–450 (2000).Crossref, Medline, CAS, Google Scholar
32 Henson JD, Neumann AA, Yeager TR, Reddel RR: Alternative lengthening of telomeres in mammalian cells. Oncogene21(4),598–610 (2002).Crossref, Medline, CAS, Google Scholar
33 Cesare AJ, Griffith JD: Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous T-loops. Mol. Cell Biol.24(22),9948–9957 (2004).Crossref, Medline, CAS, Google Scholar
34 Tokutake Y, Matsumoto T, Watanabe T et al.: Extra-chromosomal telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem. Biophys. Res. Commun.247(3),765–772 (1998).Crossref, Medline, CAS, Google Scholar
35 Groff-Vindman C, Cesare AJ, Natarajan S, Griffith JD, McEachern MJ: Recombination at long mutant telomeres produces tiny single- and double-stranded telomeric circles. Mol. Cell Biol.25(11),4406–4412 (2005).Crossref, Medline, CAS, Google Scholar
36 Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR: Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res.59(17),4175–4179 (1999).Medline, CAS, Google Scholar
37 Grobelny JV, Godwin AK, Broccoli D: ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle. J. Cell. Sci.113(Pt 24),4577–4585 (2000).Crossref, Medline, CAS, Google Scholar
38 Grobelny JV, Kulp-McEliece M, Broccoli D: Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway. Hum. Mol. Genet.10(18),1953–1961 (2001).Crossref, Medline, CAS, Google Scholar
39 Royle NJ, Foxon J, Jeyapalan JN et al.: Telomere length maintenance – an ALTernative mechanism. Cytogenet. Genome Res.122(3–4),281–291 (2008).Crossref, Medline, CAS, Google Scholar
40 Wu G, Jiang X, Lee WH, Chen PL: Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1. Cancer Res.63(10),2589–2595 (2003).Medline, CAS, Google Scholar
41 Wu G, Lee WH, Chen PL: NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem.275(39),30618–30622 (2000).Crossref, Medline, CAS, Google Scholar
42 Molenaar C, Wiesmeijer K, Verwoerd NP et al.: Visualizing telomere dynamics in living mammalian cells using PNA probes. EMBO J.22(24),6631–6641 (2003).Crossref, Medline, CAS, Google Scholar
43 Jiang WQ, Zhong ZH, Nguyen A et al.: Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins. J. Cell Biol.185(5),797–810 (2009).Crossref, Medline, CAS, Google Scholar
44 Zhong ZH, Jiang WQ, Cesare AJ, Neumann AA, Wadhwa R, Reddel RR: Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres. J. Biol. Chem.282(40),29314–29322 (2007).Crossref, Medline, CAS, Google Scholar
45 van Steensel B, Smogorzewska A, de Lange T: TRF2 protects human telomeres from end-to-end fusions. Cell92(3),401–413 (1998).Crossref, Medline, CAS, Google Scholar
46 de Lange T: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev.19(18),2100–2110 (2005).Crossref, Medline, CAS, Google Scholar
47 Baumann P, Cech TR: Pot1, the putative telomere end-binding protein in fission yeast and humans. Science292(5519),1171–1175 (2001).Crossref, Medline, CAS, Google Scholar
48 van Steensel B, de Lange T: Control of telomere length by the human telomeric protein TRF1. Nature385(6618),740–743 (1997).Crossref, Medline, CAS, Google Scholar
49 Smogorzewska A, van Steensel B, Bianchi A et al.: Control of human telomere length by TRF1 and TRF2. Mol. Cell Biol.20(5),1659–1668 (2000).Crossref, Medline, CAS, Google Scholar
50 Smith S, Giriat I, Schmitt A, de Lange T: Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science282(5393),1484–1487 (1998).Crossref, Medline, CAS, Google Scholar
51 Smith S, de Lange T: Tankyrase promotes telomere elongation in human cells. Curr. Biol.10(20),1299–1302 (2000).Crossref, Medline, CAS, Google Scholar
52 Chang W, Dynek JN, Smith S: TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres. Genes Dev.17(11),1328–1333 (2003).Crossref, Medline, CAS, Google Scholar
53 Kaminker PG, Kim SH, Taylor RD et al.: TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression. J. Biol. Chem.276(38),35891–35899 (2001).Crossref, Medline, CAS, Google Scholar
54 Cook BD, Dynek JN, Chang W, Shostak G, Smith S: Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol. Cell Biol.22(1),332–342 (2002).Crossref, Medline, CAS, Google Scholar
55 Hsiao SJ, Poitras MF, Cook BD, Liu Y, Smith S: Tankyrase 2 poly(ADP-ribose) polymerase domain-deleted mice exhibit growth defects but have normal telomere length and capping. Mol. Cell Biol.26(6),2044–2054 (2006).Crossref, Medline, CAS, Google Scholar
56 Karlseder J, Smogorzewska A, de Lange T: Senescence induced by altered telomere state, not telomere loss. Science295(5564),2446–2449 (2002).Crossref, Medline, CAS, Google Scholar
57 Stansel RM, de Lange T, Griffith JD: T-loop assembly in vitro involves binding of TRF2 near the 3´ telomeric overhang. EMBO J.20(19),5532–5540 (2001).Crossref, Medline, CAS, Google Scholar
58 Loayza D, De Lange T: POT1 as a terminal transducer of TRF1 telomere length control. Nature423(6943),1013–1018 (2003).Crossref, Medline, CAS, Google Scholar
59 Veldman T, Etheridge KT, Counter CM: Loss of hPot1 function leads to telomere instability and a cut-like phenotype. Curr. Biol.14(24),2264–2270 (2004).Crossref, Medline, CAS, Google Scholar
60 Ye JZ, Hockemeyer D, Krutchinsky AN et al.: POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev.18(14),1649–1654 (2004).Crossref, Medline, CAS, Google Scholar
61 Hockemeyer D, Daniels JP, Takai H, de Lange T: Recent expansion of the telomeric complex in rodents: two distinct POT1 proteins protect mouse telomeres. Cell126(1),63–77 (2006).Crossref, Medline, CAS, Google Scholar
62 Baumann P, Podell E, Cech TR: Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol. Cell Biol.22(22),8079–8087 (2002).Crossref, Medline, CAS, Google Scholar
63 Denchi EL, de Lange T: Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature448(7157),1068–1071 (2007).Crossref, Medline, CAS, Google Scholar
64 Ye JZ, de Lange T: TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex. Nat. Genet.36(6),618–623 (2004).Crossref, Medline, CAS, Google Scholar
65 Ye JZ, Donigian JR, van Overbeek M et al: TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. J. Biol. Chem.279(45),47264–47271 (2004).Crossref, Medline, CAS, Google Scholar
66 Hockemeyer D, Palm W, Else T et al.: Telomere protection by mammalian Pot1 requires interaction with Tpp1. Nat. Struct. Mol. Biol.14(8),754–761 (2007).Crossref, Medline, CAS, Google Scholar
67 Liu D, O’Connor MS, Qin J, Songyang Z: Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J. Biol. Chem.279(49),51338–51342 (2004).Crossref, Medline, CAS, Google Scholar
68 Liu D, Safari A, O’Connor MS et al.: PTOP interacts with POT1 and regulates its localization to telomeres. Nat. Cell Biol.6(7),673–680 (2004).Crossref, Medline, CAS, Google Scholar
69 Wang F, Podell ER, Zaug AJ et al.: The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature445(7127),506–510 (2007).Crossref, Medline, CAS, Google Scholar
70 Li B, Oestreich S, de Lange T: Identification of human Rap1: implications for telomere evolution. Cell101(5),471–483 (2000).Crossref, Medline, CAS, Google Scholar
71 O’Connor MS, Safari A, Liu D, Qin J, Songyang Z: The human Rap1 protein complex and modulation of telomere length. J. Biol. Chem.279(27),28585–28591 (2004).Crossref, Medline, Google Scholar
72 Verdun RE, Crabbe L, Haggblom C, Karlseder J: Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol. Cell20(4),551–561 (2005).Crossref, Medline, CAS, Google Scholar
73 Verdun RE, Karlseder J: The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell127(4),709–720 (2006).Crossref, Medline, CAS, Google Scholar
74 Verdun RE, Karlseder J: Replication and protection of telomeres. Nature447(7147),924–931 (2007).Crossref, Medline, CAS, Google Scholar
75 Zhu XD, Kuster B, Mann M, Petrini JH, de Lange T: Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat. Genet.25(3),347–352 (2000).Crossref, Medline, CAS, Google Scholar
76 Crabbe L, Verdun RE, Haggblom CI, Karlseder J: Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science306(5703),1951–1953 (2004).Crossref, Medline, CAS, Google Scholar
77 Yankiwski V, Marciniak RA, Guarente L, Neff NF: Nuclear structure in normal and Bloom syndrome cells. Proc. Natl Acad. Sci. USA97(10),5214–5219 (2000).Crossref, Medline, CAS, Google Scholar
78 Crabbe L, Jauch A, Naeger CM, Holtgreve-Grez H, Karlseder J: Telomere dysfunction as a cause of genomic instability in Werner syndrome. Proc. Natl Acad. Sci. USA104(7),2205–2210 (2007).Crossref, Medline, CAS, Google Scholar
79 Karlseder J: Telomeric proteins: clearing the way for the replication fork. Nat. Struct. Mol. Biol.13(5),386–387 (2006).Crossref, Medline, CAS, Google Scholar
80 Garcia-Cao M, O’Sullivan R, Peters AH, Jenuwein T, Blasco MA: Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat. Genet.36(1),94–99 (2004).▪▪ Demonstrates that histone methyltransferases SUV3-9H1 and SUV3-9H2 govern trimethylation of histone H3 lysine 9 in heterochromatic regions, including at telomeres. Loss of di- and tri-methylated histone H3 lysine 9 reduces binding of HP1 accompanied with abnormal telomere elongation and increased telomeric recombination.Crossref, Medline, CAS, Google Scholar
81 Peters AH, Kubicek S, Mechtler K et al.: Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol. Cell12(6),1577–1589 (2003).Crossref, Medline, CAS, Google Scholar
82 Peters AH, O’Carroll D, Scherthan H et al.: Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell107(3),323–337 (2001).Crossref, Medline, CAS, Google Scholar
83 Lachner M, O’Carroll D, Rea S, Mechtler K, Jenuwein T: Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature410(6824),116–120 (2001).Crossref, Medline, CAS, Google Scholar
84 Schotta G, Lachner M, Sarma K et al.: A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev.18(11),1251–1262 (2004).Crossref, Medline, CAS, Google Scholar
85 Lachner M, Jenuwein T: The many faces of histone lysine methylation. Curr. Opin Cell Biol.14(3),286–298 (2002).Crossref, Medline, CAS, Google Scholar
86 Benetti R, Gonzalo S, Jaco I et al.: Suv4–20h deficiency results in telomere elongation and derepression of telomere recombination. J. Cell Biol.178(6),925–936 (2007).▪▪ Demonstrates that SUV4-20H enzymes are responsible for trimethylation of histone H4 lysine 20 at telomeres. Cells deficient for SUV4-20H enzymes demonstrate decreased levels of H4K20me3 at telomeres and subtelomeres, increased frequencies of telomere recombination and aberrant increase in telomere length.Crossref, Medline, CAS, Google Scholar
87 Nakayama J, Rice JC, Strahl BD, Allis CD, Grewal SI: Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science292(5514),110–113 (2001).Crossref, Medline, CAS, Google Scholar
88 Bannister AJ, Zegerman P, Partridge JF et al.: Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature410(6824),120–124 (2001).Crossref, Medline, CAS, Google Scholar
89 Schotta G, Sengupta R, Kubicek S et al.: A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev.22(15),2048–2061 (2008).Crossref, Medline, CAS, Google Scholar
90 Gonzalo S, Jaco I, Fraga MF et al.: DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat. Cell Biol.8(4),416–424 (2006).▪ Demonstrates that lack of DNA methyltransferases (DNMTs) results in increased telomeric sister-chromatid exchanges, telomere-length increase and alternative lengthening of telomeres activation, suggesting a role for DNA methylation in maintaining telomere integrity.Crossref, Medline, CAS, Google Scholar
91 Garcia-Cao M, Gonzalo S, Dean D, Blasco MA: A role for the Rb family of proteins in controlling telomere length. Nat. Genet.32(3),415–419 (2002).Crossref, Medline, CAS, Google Scholar
92 Gonzalo S, Blasco MA: Role of Rb family in the epigenetic definition of chromatin. Cell Cycle4(6),752–755 (2005).Crossref, Medline, CAS, Google Scholar
93 Shanower GA, Muller M, Blanton JL, Honti V, Gyurkovics H, Schedl P: Characterization of the grappa gene, the Drosophila histone H3 lysine 79 methyltransferase. Genetics169(1),173–184 (2005).Crossref, Medline, CAS, Google Scholar
94 San-Segundo PA, Roeder GS: Role for the silencing protein Dot1 in meiotic checkpoint control. Mol. Biol. Cell11(10),3601–3615 (2000).Crossref, Medline, CAS, Google Scholar
95 Jones B, Su H, Bhat A et al.: The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet.4(9),e1000190 (2008).Crossref, Medline, Google Scholar
96 Benetti R, Garcia-Cao M, Blasco MA: Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat. Genet.39(2),243–250 (2007).Crossref, Medline, CAS, Google Scholar
97 Michishita E, McCord RA, Berber E et al.: SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature452(7186),492–496 (2008).Crossref, Medline, CAS, Google Scholar
98 Benetti R, Gonzalo S, Jaco I et al.: A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat. Struct. Mol. Biol.15(3),268–279 (2008).Crossref, Medline, CAS, Google Scholar
99 Vera E, Canela A, Fraga MF, Esteller M, Blasco MA: Epigenetic regulation of telomeres in human cancer. Oncogene27(54),6817–6833 (2008).Crossref, Medline, CAS, Google Scholar
100 Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J: Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science318(5851),798–801 (2007).▪▪ Demonstrates for the first time that telomeres are transcribed into telomeric repeat-containing RNA (TERRA). SMG proteins, which are effectors of nonsense-mediated mRNA decay negatively regulate TERRA association with chromatin and protect chromosome ends from telomere loss.Crossref, Medline, CAS, Google Scholar
101 Schoeftner S, Blasco MA. Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat. Cell Biol.10(2),228–236 (2008).▪▪ Demonstrates that TERRA telomeric repeats are transcribed by DNA-dependent RNA polymerase II, which, in turn, interacts with the TRF1 Shelterin protein. Transcription of TERRA is regulated by several mechanisms, including developmental status, telomere length, cellular stress, tumor stage and chromatin structure.Crossref, Medline, CAS, Google Scholar
102 Luke B, Lingner J: TERRA: telomeric repeat-containing RNA. EMBO J.28(17),2503–2510 (2009).Crossref, Medline, CAS, Google Scholar
103 Azzalin CM, Lingner J: Telomeres: the silence is broken. Cell Cycle7(9),1161–1165 (2008).Crossref, Medline, CAS, Google Scholar
104 Yehezkel S, Segev Y, Viegas-Pequignot E, Skorecki K, Selig S: Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum. Mol. Genet.17(18),2776–2789 (2008).Crossref, Medline, CAS, Google Scholar
105 Deng Z, Campbell AE, Lieberman PM: TERRA, CpG methylation and telomere heterochromatin: lessons from ICF syndrome cells. Cell Cycle9(1),69–74 (2010).Crossref, Medline, CAS, Google Scholar
106 Kanoh J, Francesconi S, Collura A et al.: The fission yeast spSet1p is a histone H3-K4 methyltransferase that functions in telomere maintenance and DNA repair in an ATM kinase Rad3-dependent pathway. J. Mol. Biol.326(4),1081–1094 (2003).Crossref, Medline, CAS, Google Scholar
107 Krogan NJ, Dover J, Khorrami S et al.: COMPASS, a histone H3 (lysine 4) methyltransferase required for telomeric silencing of gene expression. J. Biol. Chem.277(13),10753–10755 (2002).Crossref, Medline, CAS, Google Scholar
108 Caslini C, Connelly JA, Serna A, Broccoli D, Hess JL: MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription. Mol. Cell Biol.29(16),4519–4526 (2009).Crossref, Medline, CAS, Google Scholar
109 Ng LJ, Cropley JE, Pickett HA, Reddel RR, Suter CM: Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res.37(4),1152–1159 (2009).Crossref, Medline, CAS, Google Scholar
110 Deng Z, Norseen J, Wiedmer A, Riethman H, Lieberman PM: TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol. Cell35(4),403–413 (2009).Crossref, Medline, CAS, Google Scholar
111 Hande MP, Samper E, Lansdorp P, Blasco MA: Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol.144(4),589–601 (1999).Crossref, Medline, CAS, Google Scholar
112 Rudolph KL, Chang S, Lee HW et al.: Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell96(5),701–712 (1999).Crossref, Medline, CAS, Google Scholar
113 Niida H, Shinkai Y, Hande MP et al.: Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA. Mol. Cell Biol.20(11),4115–4127 (2000).Crossref, Medline, CAS, Google Scholar
114 Tilman G, Loriot A, van Beneden A et al.: Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells. Oncogene28(14),1682–1693 (2009).Crossref, Medline, CAS, Google Scholar
115 Benetti R, Schoeftner S, Munoz P, Blasco MA: Role of TRF2 in the assembly of telomeric chromatin. Cell Cycle7(21),3461–3468 (2008).Crossref, Medline, CAS, Google Scholar
116 Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, Misteli T: Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev. Cell10(1),105–116 (2006).Crossref, Medline, CAS, Google Scholar
117 Meshorer E, Misteli T: Chromatin in pluripotent embryonic stem cells and differentiation. Nat. Rev. Mol. Cell Biol.7(7),540–546 (2006).Crossref, Medline, CAS, Google Scholar
118 Azuara V, Perry P, Sauer S et al.: Chromatin signatures of pluripotent cell lines. Nat. Cell Biol.8(5),532–538 (2006).Crossref, Medline, CAS, Google Scholar
119 Bibikova M, Laurent LC, Ren B, Loring JF, Fan JB: Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell2(2),123–134 (2008).Crossref, Medline, CAS, Google Scholar
120 Bernstein BE, Mikkelsen TS, Xie X et al.: A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell125(2),315–326 (2006).Crossref, Medline, CAS, Google Scholar
121 Boyer LA, Plath K, Zeitlinger J et al.: Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature441(7091),349–353 (2006).Crossref, Medline, CAS, Google Scholar
122 Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K: Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev.20(9),1123–1136 (2006).Crossref, Medline, CAS, Google Scholar
123 Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell131(5),861–872 (2007).Crossref, Medline, CAS, Google Scholar
124 Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126(4),663–676 (2006).Crossref, Medline, CAS, Google Scholar
125 Maherali N, Hochedlinger K: Induced pluripotency of mouse and human somatic cells. Cold Spring Harb. Symp. Quant. Biol.73,157–162 (2008).Crossref, Medline, CAS, Google Scholar
126 Blasco MA: Telomeres and human disease: ageing, cancer and beyond. Nat. Rev.6(8),611–622 (2005).Crossref, CAS, Google Scholar
127 Blasco MA: Telomere length, stem cells and aging. Nat. Chem. Biol.3(10),640–649 (2007).Crossref, Medline, CAS, Google Scholar
128 Hiyama E, Hiyama K: Telomere and telomerase in stem cells. Br. J. Cancer96(7),1020–1024 (2007).Crossref, Medline, CAS, Google Scholar
129 Sarin KY, Cheung P, Gilison D et al.: Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature436(7053),1048–1052 (2005).Crossref, Medline, CAS, Google Scholar
130 Flores I, Canela A, Vera E, Tejera A, Cotsarelis G, Blasco MA: The longest telomeres: a general signature of adult stem cell compartments. Genes Dev.22(5),654–667 (2008).▪▪ Demonstrates that the longest telomeres are a general feature of stem cell compartments in mice. The progressive shortening of telomeres with age in various stem cell compartments parallels a decline in stem cell functionality, providing evidence that telomere loss may contribute to stem cell dysfunction with age.Crossref, Medline, CAS, Google Scholar
131 Siegl-Cachedenier I, Flores I, Klatt P, Blasco MA: Telomerase reverses epidermal hair follicle stem cell defects and loss of long-term survival associated with critically short telomeres. J. Cell Biol.179(2),277–290 (2007).Crossref, Medline, CAS, Google Scholar
132 Liu L, Bailey SM, Okuka M et al.: Telomere lengthening early in development. Nat. Cell Biol.9(12),1436–1441 (2007).Crossref, Medline, CAS, Google Scholar
133 Marion RM, Strati K, Li H et al.: Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell4(2),141–154 (2009).▪▪ Demonstrates that during induced pluripotent stem cell generation, telomeres increase in length and acquire embryonic stem cell-like epigenetic marks at telomeres, including a low density of H3K9me3 and H4K20me3 and an increase in TERRA level. Reprogramming of telomerase-null cells to induced pluripotent cells is highly inefficient and this defect can be restored by the reintroduction of telomerase, highlighting the importance of telomere biology for stem cell pluripotency and functionality.Crossref, Medline, CAS, Google Scholar
134 Wong LH, Ren H, Williams E et al.: Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells. Genome Res.19(3),404–414 (2009).▪▪ Demonstrates that histone variant H3.3 is an essential component of telomere chromatin in embryonic stem cells.Crossref, Medline, CAS, Google Scholar
135 Ishov AM, Vladimirova OV, Maul GG: Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX. J. Cell. Sci.117(Pt 17),3807–3820 (2004).Crossref, Medline, CAS, Google Scholar
136 Kourmouli N, Sun YM, van der Sar S, Singh PB, Brown JP: Epigenetic regulation of mammalian pericentric heterochromatin in vivo by HP1. Biochem. Biophys. Res. Commun.337(3),901–907 (2005).Crossref, Medline, CAS, Google Scholar
137 McDowell TL, Gibbons RJ, Sutherland H et al.: Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. Proc. Natl Acad. Sci. USA96(24),13983–13988 (1999).Crossref, Medline, CAS, Google Scholar
138 Nan X, Hou J, Maclean A et al.: Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc. Natl Acad. Sci. USA104(8),2709–2714 (2007).Crossref, Medline, CAS, Google Scholar
139 Xue Y, Gibbons R, Yan Z et al.: The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc. Natl Acad. Sci. USA100(19),10635–10640 (2003).Crossref, Medline, CAS, Google Scholar
140 Wong LH, McGhie JD, Sim M et al.: ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Res.20(3),351–360 (2010).▪▪ Demonstrates the interaction between H3.3 and ATRX at telomeres in embryonic stem cells. ATRX acts as an essential part of telomeric chromatin and is required for the recruitment of HP1 at telomeres in these cells.Crossref, Medline, CAS, Google Scholar
141 Goldberg AD, Banaszynski LA, Noh KM et al.: Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell140(5),678–691 (2010).Crossref, Medline, CAS, Google Scholar
142 Wakayama T, Rodriguez I, Perry AC, Yanagimachi R, Mombaerts P: Mice cloned from embryonic stem cells. Proc. Natl Acad. Sci. USA96(26),14984–14989 (1999).Crossref, Medline, CAS, Google Scholar
143 Lanza RP, Cibelli JB, Blackwell C et al.: Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science288(5466),665–669 (2000).Crossref, Medline, CAS, Google Scholar
144 Betts D, Bordignon V, Hill J et al.: Reprogramming of telomerase activity and rebuilding of telomere length in cloned cattle. Proc. Natl Acad. Sci. USA98(3),1077–1082 (2001).Crossref, Medline, CAS, Google Scholar
145 Tian XC, Xu J, Yang X: Normal telomere lengths found in cloned cattle. Nat. Genet.26(3),272–273 (2000).Crossref, Medline, CAS, Google Scholar
146 Shiels PG, Kind AJ, Campbell KH et al.: Analysis of telomere lengths in cloned sheep. Nature399(6734),1316–1317 (1999).Crossref, Google Scholar
147 Agarwal S, Loh YH, McLoughlin EM et al.: Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature464(7286),292–296 (2010).Crossref, Medline, CAS, Google Scholar
148 Marion RM, Strati K, Li H et al.: A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature460(7259),1149–1153 (2009)Crossref, Medline, CAS, Google Scholar
149 Nakano M, Cardinale S, Noskov VN et al.: Inactivation of a human kinetochore by specific targeting of chromatin modifiers. Dev. Cell14(4),507–522 (2008).Crossref, Medline, CAS, Google Scholar

Vol. 2, No. 5

Metrics

Downloaded 336 times

History

Published online 9 November 2010

Published in print October 2010

Information

Keywords

Financial & competing interests disclosure

The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

PDF download

Epigenetic regulation of telomere chromatin integrity in pluripotent embryonic stem cells

Abstract

Bibliography